FIGURE 6.
Whole-body (maximum-intensity projection) image (left) and 89Zr-IAB22M2C (0.5 mg) images (right) of patient with hepatocellular carcinoma. 89Zr-IAB22M2C–positive lesions are seen in 2 liver metastases (SUVmax, 14.6 and 22.85), and additional uptake is seen in 3 abdominal lymph node metastases (SUVmax, 5.85–10.9).